Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01819233 · ClinicalTrials.gov registry record · NA

Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation Therapy

A NA study, sponsored by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University.

Completed
Registry status
NA
Development phase
38
Enrollment target

NCT01819233 is a NA study that has completed, run by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University. The registered enrollment target is 38 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01819233, a NA study, has completed, sponsored by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University.

COMPLETED
Registry status
NA
Development phase
38 participants
Enrollment target

Study Summary

This pilot clinical trial studies caloric restriction in patients with stage 0-I breast cancer during surgery and radiation therapy. Reducing caloric intake may prevent disease progression in patients with breast cancer. Radiation therapy uses high energy x rays to kill tumor cells. Giving dietary intervention and radiation therapy together may kill more tumor cells.

Interventions

  • RADIATION Radiation therapy
  • PROCEDURE Quality-of-life assessment
  • OTHER Counseling intervention
  • BEHAVIORAL Behavioral dietary intervention
  • PROCEDURE Therapeutic conventional surgery

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2013-03-08
Est. Completion 2019-09
Phase NA

What the Registry Record Tells You About NCT01819233

The ClinicalTrials.gov registry entry for NCT01819233 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, which has 138 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which Radiation therapy is the first listed.

NCT01819233 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01819233 about?

NCT01819233 is a clinical study titled "Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation Therapy". This pilot clinical trial studies caloric restriction in patients with stage 0-I breast cancer during surgery and radiation therapy. Reducing caloric intake may prevent disease progression in patients with breast cancer. Radiation therapy uses high energy x rays to kill tumor cells. Giving dietary i...

What is the current status of trial NCT01819233?

This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2013-03-08. Estimated completion is 2019-09.

What interventions are being tested in trial NCT01819233?

The interventions under investigation include: Radiation therapy (RADIATION), Quality-of-life assessment (PROCEDURE), Counseling intervention (OTHER), Behavioral dietary intervention (BEHAVIORAL), Therapeutic conventional surgery (PROCEDURE).

Who is sponsoring clinical trial NCT01819233?

This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, which has 138 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.